Yang-Yi Fan
Research Subjects
Yang-Yi Fan has a total of 29 co-authors. Here are the top co-authors by number of shared publications:
- Robert S. Chapkin
Department of Nutrition, Texas A&M University, College Station, TX 77843, USA
5 shared publications David N. McMurray
Program in Integrative Nutrition and Complex Diseases,Departments of Nutrition & Food Science,Texas A&M University,College Station, TX 77843,USA
2 shared publicationsKenneth S. Ramos
2 shared publicationsAlexis Wilson
Department of Pharmacology, School of Medicine, Wayne State University, Detroit, MI 48201, USA; Department of Oncology, School of Medicine, Wayne State University, and Karmanos Cancer Institute, Detroit, MI 48201, USA
1 shared publication- Brad Weeks
Veterinary Pathobiology, Texas A&M University, College Station, TX, USA
1 shared publication Evelyn Callaway
Program in Integrative Nutrition & Complex Diseases, Center for Translational Environmental Health Research, Texas A&M University, College Station, TX, USA
1 shared publication
Latest Publications
- Open Access
- 23 March 2025
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 186, 118006
Targeting polyunsaturated fatty acids desaturase FADS1 inhibits renal cancer growth via ATF3-mediated ER stress response
- 23 March 2025
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 186, 118006
Open AccessTargeting polyunsaturated fatty acids desaturase FADS1 inhibits renal cancer growth via ATF3-mediated ER stress response
- Open Access
- 18 December 2017
- Published by Cambridge University Press (CUP) in British Journal of Nutrition
- Vol. 119 (2) , 163-175
Remodelling of primary human CD4+T cell plasma membrane order byn-3 PUFA
Cell membrane fatty acids influence fundamental properties of the plasma membrane, including membrane fluidity, protein functionality, and lipid raft signalling. Evidence suggests that dietaryn-3 PUFA may target the plasma membrane of immune cells by altering plasma membrane lipid dynamics, thereby regulating the attenuation of immune cell activation and suppression of inflammation. As lipid-based immunotherapy might be a promising new clinical strategy for the treatment of inflammatory disorders, we conductedin vitroandin vivoexperiments to examine the effects ofn-3 PUFA on CD4+T cell membrane order, mitochondrial bioenergetics and lymphoproliferation.n-3 PUFA were incorporated into human primary CD4+T cells phospholipidsin vitroin a dose-dependent manner, resulting in a reduction in whole cell membrane order, oxidative phosphorylation and proliferation. At higher doses,n-3 PUFA induced unique phase separation in T cell-derived giant plasma membrane vesicles. Similarly, in a short-term human pilot study, supplementation of fish oil (4 gn-3 PUFA/d) for 6 weeks in healthy subjects significantly elevated EPA (20 : 5n-3) levels in CD4+T cell membrane phospholipids, and reduced membrane lipid order. These results demonstrate that the dynamic reshaping of human CD4+T cell plasma membrane organisation byn-3 PUFA may modulate down-stream clonal expansion.
- 18 December 2017
- Published by Cambridge University Press (CUP) in British Journal of Nutrition
- Vol. 119 (2) , 163-175
Open AccessRemodelling of primary human CD4+T cell plasma membrane order byn-3 PUFA
Cell membrane fatty acids influence fundamental properties of the plasma membrane, including membrane fluidity, protein functionality, and lipid raft signalling. Evidence suggests that dietaryn-3 PUFA may target the plasma membrane of immune cells by altering plasma membrane lipid dynamics, thereby regulating the attenuation of immune cell activation and suppression of inflammation. As lipid-based immunotherapy might be a promising new clinical strategy for the treatment of inflammatory disorders, we conductedin vitroandin vivoexperiments to examine the effects ofn-3 PUFA on CD4+T cell membrane order, mitochondrial bioenergetics and lymphoproliferation.n-3 PUFA were incorporated into human primary CD4+T cells phospholipidsin vitroin a dose-dependent manner, resulting in a reduction in whole cell membrane order, oxidative phosphorylation and proliferation. At higher doses,n-3 PUFA induced unique phase separation in T cell-derived giant plasma membrane vesicles. Similarly, in a short-term human pilot study, supplementation of fish oil (4 gn-3 PUFA/d) for 6 weeks in healthy subjects significantly elevated EPA (20 : 5n-3) levels in CD4+T cell membrane phospholipids, and reduced membrane lipid order. These results demonstrate that the dynamic reshaping of human CD4+T cell plasma membrane organisation byn-3 PUFA may modulate down-stream clonal expansion.
- Open Access
- 17 July 2014
- Published by Wiley in Mediators of Inflammation
- Vol. 2014, 1-14
Antagonizing Arachidonic Acid-Derived Eicosanoids Reduces Inflammatory Th17 and Th1 Cell-Mediated Inflammation and Colitis Severity
During colitis, activation of two inflammatory T cell subsets, Th17 and Th1 cells, promotes ongoing intestinal inflammatory responses. n-6 polyunsaturated fatty acid- (PUFA-) derived eicosanoids, such as prostaglandin E2(PGE2), promote Th17 cell-mediated inflammation, while n-3 PUFA antagonize both Th17 and Th1 cells and suppress PGE2levels. We utilized two genetic mouse models, which differentially antagonize PGE2levels, to examine the effect on Th17 cells and disease outcomes in trinitrobenzene sulfonic acid- (TNBS-) induced colitis.Fat-1mice contain the3 desaturase gene fromC. elegansand synthesize n-3 PUFAde novo, thereby reducing the biosynthesis of n-6 PUFA-derived eicosanoids. In contrast,Fads1Null mice contain a disrupteddesaturase gene and produce lower levels of n-6 PUFA-derived eicosanoids. Compared to Wt littermates,Fat-1andFads1Null mice exhibited a similar colitic phenotype characterized by reduced colonic mucosal inflammatory eicosanoid levels and mRNA expression of Th17 cell markers (IL-17A,, and IL-23), decreased percentages of Th17 cells and, improved colon injury scores (). Thus, during colitis, similar outcomes were obtained in two genetically distinct models, both of which antagonize PGE2levels via different mechanisms. Our data highlight the critical impact of n-6 PUFA-derived eicosanoids in the promotion of Th17 cell-mediated colonic inflammation.- 17 July 2014
- Published by Wiley in Mediators of Inflammation
- Vol. 2014, 1-14
Open AccessAntagonizing Arachidonic Acid-Derived Eicosanoids Reduces Inflammatory Th17 and Th1 Cell-Mediated Inflammation and Colitis Severity
During colitis, activation of two inflammatory T cell subsets, Th17 and Th1 cells, promotes ongoing intestinal inflammatory responses. n-6 polyunsaturated fatty acid- (PUFA-) derived eicosanoids, such as prostaglandin E2(PGE2), promote Th17 cell-mediated inflammation, while n-3 PUFA antagonize both Th17 and Th1 cells and suppress PGE2levels. We utilized two genetic mouse models, which differentially antagonize PGE2levels, to examine the effect on Th17 cells and disease outcomes in trinitrobenzene sulfonic acid- (TNBS-) induced colitis.Fat-1mice contain the3 desaturase gene fromC. elegansand synthesize n-3 PUFAde novo, thereby reducing the biosynthesis of n-6 PUFA-derived eicosanoids. In contrast,Fads1Null mice contain a disrupteddesaturase gene and produce lower levels of n-6 PUFA-derived eicosanoids. Compared to Wt littermates,Fat-1andFads1Null mice exhibited a similar colitic phenotype characterized by reduced colonic mucosal inflammatory eicosanoid levels and mRNA expression of Th17 cell markers (IL-17A,, and IL-23), decreased percentages of Th17 cells and, improved colon injury scores (). Thus, during colitis, similar outcomes were obtained in two genetically distinct models, both of which antagonize PGE2levels via different mechanisms. Our data highlight the critical impact of n-6 PUFA-derived eicosanoids in the promotion of Th17 cell-mediated colonic inflammation. - 1 August 2004
- Published by Elsevier in Biochemical Pharmacology
- Vol. 68 (3) , 503-512
Interactions of phospholipase D and cytochrome P450 protein stability
- 1 August 2004
- Published by Elsevier in Biochemical Pharmacology
- Vol. 68 (3) , 503-512
Interactions of phospholipase D and cytochrome P450 protein stability
- 1 July 1997
- Published by Taylor & Francis in Journal of Toxicology and Environmental Health
- Vol. 51 (4) , 369-386
GROWTH-RELATED SIGNALING IN VASCULAR SMOOTH MUSCLE CELLS IS DEREGULATED BY TCDD DURING THE G /G TRANSITION 0 1
Search and browse 5 million articles across 13,000 publications from over 250 publishers by publication, subject, publisher, author or keyword.
- 1 July 1997
- Published by Taylor & Francis in Journal of Toxicology and Environmental Health
- Vol. 51 (4) , 369-386
GROWTH-RELATED SIGNALING IN VASCULAR SMOOTH MUSCLE CELLS IS DEREGULATED BY TCDD DURING THE G /G TRANSITION 0 1
Search and browse 5 million articles across 13,000 publications from over 250 publishers by publication, subject, publisher, author or keyword.
- 1 September 1995
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 15 (9) , 1397-1403
Dietary γ-Linolenic Acid Modulates Macrophage–Vascular Smooth Muscle Cell Interactions
Macrophages and smooth muscle cells (SMCs) are two of the major reactive cell types in atherosclerosis, a disease characterized by uncontrolled proliferation of SMCs. The present study was designed to determine how dietary oils containing γ-linolenic acid (GLA) (primrose oil [PO]) and long-chain n-3 fatty acids (fish oil) influence the ability of macrophages to modulate SMC DNA synthesis in vitro. Mice were fed one of four diets containing 10% (wt/wt) corn oil (CO), PO, fish oil–CO mix (FC; 9:1, wt/wt), or fish oil–PO mix (FP; 1:3, wt/wt) for 2 weeks. Resident peritoneal macrophages were isolated from these mice and seeded on a semipermeable membrane with a 30-kDa cutoff. Macrophages were preincubated with or without 50 μmol/L indomethacin (a cyclooxygenase inhibitor) or 50 μmol/L L655,238 (a 5-lipoxygenase inhibitor) for 30 minutes and subsequently cocultured with naive murine aortic SMCs grown on culture dishes. DNA synthesis in SMCs and prostaglandin formation in coculture supernatants were measured at the end of a 39-hour incubation period. SMC DNA synthesis was inhibited by 28% and 60% in PO and FP diets containing 10.1% and 8.2% GLA, respectively, relative to the control CO diet containing no GLA or long-chain n-3 fatty acid. A fourfold increase in the levels of PGE1, a potent antiproliferative eicosanoid derived from GLA, was observed in the PO and FP groups relative to the control CO group. Although PGE1levels were not different between the CO and FC dietary groups, 15% inhibition of SMC DNA synthesis, relative to that in mice fed the control CO diet, was observed in mice fed the FC diet containing 13.3% 20:5n-3 and 7.6% 22:6n-3 fatty acids. Macrophage inhibition of SMC DNA synthesis and proliferation in mice consuming GLA-enriched diets was blocked by indomethacin but not by L655,238. Addition of exogenous PGE1(100 nmol/L) reversed the effect of indomethacin. In experiments in which mice were fed increasing levels of GLA-containing triglycerides, the ability of macrophages to downregulate SMC proliferation was modulated in a dose-dependent fashion. These data indicate that macrophages isolated from animals consuming diets supplemented with dietary oils containing GLA reduce SMC DNA synthesis and proliferation in a cyclooxygenase-dependent manner and therefore may favorably modulate the atherogenic process.
- 1 September 1995
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 15 (9) , 1397-1403
Dietary γ-Linolenic Acid Modulates Macrophage–Vascular Smooth Muscle Cell Interactions
Macrophages and smooth muscle cells (SMCs) are two of the major reactive cell types in atherosclerosis, a disease characterized by uncontrolled proliferation of SMCs. The present study was designed to determine how dietary oils containing γ-linolenic acid (GLA) (primrose oil [PO]) and long-chain n-3 fatty acids (fish oil) influence the ability of macrophages to modulate SMC DNA synthesis in vitro. Mice were fed one of four diets containing 10% (wt/wt) corn oil (CO), PO, fish oil–CO mix (FC; 9:1, wt/wt), or fish oil–PO mix (FP; 1:3, wt/wt) for 2 weeks. Resident peritoneal macrophages were isolated from these mice and seeded on a semipermeable membrane with a 30-kDa cutoff. Macrophages were preincubated with or without 50 μmol/L indomethacin (a cyclooxygenase inhibitor) or 50 μmol/L L655,238 (a 5-lipoxygenase inhibitor) for 30 minutes and subsequently cocultured with naive murine aortic SMCs grown on culture dishes. DNA synthesis in SMCs and prostaglandin formation in coculture supernatants were measured at the end of a 39-hour incubation period. SMC DNA synthesis was inhibited by 28% and 60% in PO and FP diets containing 10.1% and 8.2% GLA, respectively, relative to the control CO diet containing no GLA or long-chain n-3 fatty acid. A fourfold increase in the levels of PGE1, a potent antiproliferative eicosanoid derived from GLA, was observed in the PO and FP groups relative to the control CO group. Although PGE1levels were not different between the CO and FC dietary groups, 15% inhibition of SMC DNA synthesis, relative to that in mice fed the control CO diet, was observed in mice fed the FC diet containing 13.3% 20:5n-3 and 7.6% 22:6n-3 fatty acids. Macrophage inhibition of SMC DNA synthesis and proliferation in mice consuming GLA-enriched diets was blocked by indomethacin but not by L655,238. Addition of exogenous PGE1(100 nmol/L) reversed the effect of indomethacin. In experiments in which mice were fed increasing levels of GLA-containing triglycerides, the ability of macrophages to downregulate SMC proliferation was modulated in a dose-dependent fashion. These data indicate that macrophages isolated from animals consuming diets supplemented with dietary oils containing GLA reduce SMC DNA synthesis and proliferation in a cyclooxygenase-dependent manner and therefore may favorably modulate the atherogenic process.